RE:RE:RE:RE:RE:RE:MakstocksInterestingly, it seems Rimbus has gained a following thru persistently down grading Neovasc and stating the obvious; that is, what the Company has already made clear several times regarding dilution and risk. But there lies the difference: either you are invested in this Company and hence own it and effectively, not affectively, have researched the risks involved, or you are in it for quick profit as is Rimbus. I am not a pumper, but a share holder who is invested and sees significant possibilities in this even after its share consolidation. So, if this stock becomes even more diluted and the share price drops, I will add a significant lot more to my portfolio and ready this for the consolidation. Medical and Biotech are risky ventures regardless due to the nature of the competitiveness involved. Here is the
link to Neovascs Filing of Annual Report on Form 20-F: 20-F Read carefully and weigh the stated risks against the potential upside.
The Company has the following seven wholly-owned subsidiaries:
| | | | | |
| Name: | | Date of Incorporation: | | Jurisdiction of Incorporation: |
| Neovasc Medical Inc. (formerly PM Devices Inc.) | | May 7, 1998 | | British Columbia |
| Neovasc Tiara Inc. | | March 11, 2013 | | Canada (federal) |
| Neovasc Medical Ltd. | | September 9, 2002 | | Israel |
| Neovasc (US) Inc. (formerly Medical Ventures (US) Inc.) | | July 2, 2007 | | United States |
| B-Balloon Ltd.(1) | | March 30, 2004 | | Israel |
| Neovasc GmbH | | August 14, 2017 | | Germany |
| Neovasc Management Inc. | | January 23, 2018 | | United States |
- (1)
- B-Balloon Ltd. is in the process of being voluntarily wound up.